Synactix is derived from synergy and action.
All of our drug discovery projects are centered on single-agents with distinct, multi-targeted profiles.
With this approach, we are committed to developing and commercializing therapies with the potential to improve or cure human disease by targeting multiple,
cooperating disease pathways. We have established a broad development platform, laying the foundation for our continued efforts to bring new therapies to patients in need.
In addition, we are leveraging our earlier stage drug discovery and development capabilities to establish partnerships
and collaborations with leading pharmaceutical, biopharmaceutical, and academic partners.
These alliances are designed to advance the development of Synactix-discovered therapies.
Please call 1-800-336-1752 or email email@example.com for more information.
Current Partners of Synactix
Arizona Center for Innovation (AzCI): Synactix participates in the Mentored Launch program with the AzCI, receiving personal business mentoring and access to a large support and partnering network across Arizona. Synactix also maintains their laboratory in the AzCI GLP qualified laboratory facilities.
Tech Launch Arizona (TLA): Tech Launch Arizona at the University of Arizona is focused on connecting researchers to a broad network of industry and domain experts, business leaders, commercialization partners and potential investors, all focused on driving commercial success.
© 2016. All Rights reserved by Synactix Pharmaceuticals, Inc. | Designed by CityX